新闻
CMS: Approval Of Drug Clinical Trials For Overweight/Obesity Indication Of Self-Developed Innovative Drug INHBE-Targeting Small Nucleic Acid Drug CMS-D008.
05 Mar 2026 10:18The National Medical Products Administration has approved the conduct of clinical trials of CMS-D008 injection for overweight or obese individuals...
Attachments:
Source: ShareInvestor Express
